Various risk factors have been identified and associated with the risk of brain metastatic breast cancer (BC), with one of the most recent systematic reviews including younger age, estrogen receptor (ER)-negative status, HER2-positive status, higher tumor stage, higher histologic grade, large tumor size and high Ki67 labelling index as independent risk factors [4,5]. This evidence concerns the gene ERBB2 and neoplasm.